[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Sarepta Therapeutics

Wedbush initiates Sarepta Therapeutics stock coverage with an Outperform rating and a $XX price target, suggesting potential upside. This comes amidst ongoing discussions about Elevidys and Duchenne trials.

### About Sarepta Therapeutics
Sarepta Therapeutics is a biotechnology company focused on gene therapies for rare diseases.  

### Insights
- sarepta therapeutics sentiment is up XXXXX% from the previous week.
- sarepta therapeutics creators is up XX% from the previous week.
- sarepta therapeutics mentions is up XX% from the previous week.
- sarepta therapeutics posts created is up XXX% from the previous week.

### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:sarepta-therapeutics/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/sarepta-therapeutics/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXXXXX  
X Week: XXXXX +1.30%  
X Month: XXXXXX -XX%  
X Months: XXXXXXXXX +757%  
X Year: XXXXXXXXX +440%  
1-Year High: XXXXXXX on 2025-08-05  
1-Year Low: X on 2025-11-08  

Engagements by network (24h):
News: XX
Reddit: XXX
TikTok: X
X: XXX
YouTube: XX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:sarepta-therapeutics/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/sarepta-therapeutics/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XXX +50%  
X Month: XXX -XX%  
X Months: XXXXX +119%  
X Year: XXXXX +159%  
1-Year High: XXX on 2025-07-18  
1-Year Low: X on 2025-11-04  

Mentions by network (24h):
News: XX
Reddit: XX
TikTok: X
X: XX
YouTube: X

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:sarepta-therapeutics/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/sarepta-therapeutics/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Sarepta Therapeutics in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XX +40%  
X Month: XXX -XX%  
X Months: XXX +132%  
X Year: XXXXX +176%  
1-Year High: XXX on 2025-07-18  
1-Year Low: X on 2025-01-26  

The most influential creators that mention Sarepta Therapeutics in the last XX hours

| Creator                                                       | Rank | Followers | Posts | Engagements |
| -------                                                       | ---- | --------- | ----- | ----------- |
| [@allday_stocks](/creator/twitter/allday_stocks)              | X    | XXXXX     | X     | XX          |
| [@Sarepta](/creator/twitter/Sarepta)                          | X    | XXXXX     | X     | XX          |
| [@sareptatherapeutics](/creator/youtube/sareptatherapeutics)  | X    | XXXXX     | X     | XX          |
| [@Capital_Letterhead49](/creator/reddit/Capital_Letterhead49) | X    |           | X     | XX          |
| [@Stock_Titan](/creator/reddit/Stock_Titan)                   | X    | XXXXX     | X     | X           |

[View More](/list/creators/sarepta-therapeutics/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:sarepta-therapeutics/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/sarepta-therapeutics/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XXX% +33%  
X Month: XX% -XX%  
X Months: XX% +1%  
X Year: XX% -XX%  
1-Year High: XXX% on 2024-12-12  
1-Year Low: XX% on 2025-03-18  

Most Supportive Themes:
- Scholarship Program Announcement: (30%) Sarepta Therapeutics announced recipients of the Route XX Duchenne Scholarship Program for 2025-2026.
  
Most Critical Themes:
- Duchenne Trial Failure: (30%) Sarepta's late-stage Duchenne trial for AMONDYS XX and VYONDYS XX failed to meet its primary endpoint.
- Elevidys Challenges and Restructuring: (25%) Sarepta Therapeutics is facing challenges with its Elevidys drug, leading to restructuring.
- Safety Concerns and Investigations: (15%) There are investigations into the safety of Sarepta's Elevidys drug.
  

### Top Sarepta Therapeutics News
Top news links shared on social in the last XX hours  

*Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.*  

"Wedbush initiates Sarepta Therapeutics stock coverage with Outperform rating By Investing.com"  
[News Link](https://www.investing.com/news/analyst-ratings/wedbush-initiates-sarepta-therapeutics-stock-coverage-with-outperform-rating-93CH-4398384) [@Investingcom](/creator/x/Investingcom) 2025-12-10T00:32Z 1.4M followers, XXX engagements


"Why Is Sarepta Therapeutics (SRPT) Up XXXX% Since Last Earnings Report Nasdaq"  
[News Link](https://www.nasdaq.com/articles/why-sarepta-therapeutics-srpt-264-last-earnings-report) [@Nasdaq](/creator/x/Nasdaq) 2025-12-09T16:52Z 165.8K followers, XX engagements



### Top Sarepta Therapeutics Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Buy Signal Sarepta Therapeutics Inc - XX Dec 2025 @ 10:39 - USD22.16"  
[Reddit Link](https://redd.it/1pj5rpq) [@jvc72](/creator/reddit/jvc72) 2025-12-10T15:44Z X followers, X engagements


"$SRAD -UBS lowers Sportradar target to $XX from $XX Buy - $SRPT -Wedbush initiates Sarepta Therapeutics coverage at Outperform believing early Summer sell-off due to Elevidys patient deaths was overdone Sets $XX target"  
[X Link](https://x.com/MarcJacksonLA/status/1998551399840494038) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2025-12-10T00:32Z 7635 followers, XXX engagements


"Why Is Sarepta Therapeutics (SRPT) Up XXXX% Since Last Earnings Report"  
[X Link](https://x.com/tickerade/status/1998435502291026199) [@tickerade](/creator/x/tickerade) 2025-12-09T16:52Z XX followers, XX engagements


"$SRPT Sarepta Therapeutics initiated at Wedbush Rating: Outperform Price Target: $XX (vs. $XXXX current) Upside: 45%"  
[X Link](https://x.com/allday_stocks/status/1998385557081088358) [@allday_stocks](/creator/x/allday_stocks) 2025-12-09T13:33Z 2308 followers, XXX engagements